Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force

Ives C. Passos, Pedro L. Ballester, Rodrigo C. Barros, Diego Librenza-Garcia, Benson Mwangi, Boris Birmaher, Elisa Brietzke, Tomas Hajek, Carlos Lopez Jaramillo, Rodrigo B. Mansur, Martin Alda, Bartholomeus C.M. Haarman, Erkki Isometsa, Raymond W. Lam, Roger S. McIntyre, Luciano Minuzzi, Lars V. Kessing, Lakshmi N. Yatham, Anne Duffy, Flavio Kapczinski

Résultat de recherche: Review articleexamen par les pairs

59 Citations (Scopus)

Résumé

Objectives: The International Society for Bipolar Disorders Big Data Task Force assembled leading researchers in the field of bipolar disorder (BD), machine learning, and big data with extensive experience to evaluate the rationale of machine learning and big data analytics strategies for BD. Method: A task force was convened to examine and integrate findings from the scientific literature related to machine learning and big data based studies to clarify terminology and to describe challenges and potential applications in the field of BD. We also systematically searched PubMed, Embase, and Web of Science for articles published up to January 2019 that used machine learning in BD. Results: The results suggested that big data analytics has the potential to provide risk calculators to aid in treatment decisions and predict clinical prognosis, including suicidality, for individual patients. This approach can advance diagnosis by enabling discovery of more relevant data-driven phenotypes, as well as by predicting transition to the disorder in high-risk unaffected subjects. We also discuss the most frequent challenges that big data analytics applications can face, such as heterogeneity, lack of external validation and replication of some studies, cost and non-stationary distribution of the data, and lack of appropriate funding. Conclusion: Machine learning-based studies, including atheoretical data-driven big data approaches, provide an opportunity to more accurately detect those who are at risk, parse-relevant phenotypes as well as inform treatment selection and prognosis. However, several methodological challenges need to be addressed in order to translate research findings to clinical settings.

Langue d'origineEnglish
Pages (de-à)582-594
Nombre de pages13
JournalBipolar Disorders
Volume21
Numéro de publication7
DOI
Statut de publicationPublished - nov. 1 2019

Note bibliographique

Funding Information:
Ives Cavalcante Passos was supported by funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and CAPES (Brazilian Government) and FIPE (Hospital de Clínicas de Porto Alegre). Tomas Hajek was supported by funding from the Canadian Institutes of Health Research (103703, 106469 and 142255), Nova Scotia Health Research Foundation, Dalhousie Clinical Research Scholarship, Brain & Behavior Research Foundation (formerly NARSAD), 2007 Young Investigator and 2015 Independent Investigator Awards, the Ministry of Health, Czech Republic (grants number 16-32791A, 16-32696A). Flávio Kapczinski has received grants or research support from Brain & Behavior Research Foundation (formerly NARSAD), the Stanley Medical Research Institute, CNPq, and CAPES (Brazilian Government). Dr. McIntyre's Research or Grants from Private Industries or Non-Profit Funds: Stanley Medical Research Institute, CIHR/GACD/Chinese National Natural Research Foundation. Consultation/Speaker Fees: Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva. Dr. Brietzke has received research grants or research support from FAPESP, CNPq, and CAPES (Brazilian Government), from the Southeastern Ontario Academic Medical Association (SEAMO), from Faculty of Health Sciences, Queen's University and from a L'Oreal / UNESCO/ Brazilian Academy of Sciences for Women in Science Award. She has received honorarium as consultant/advisory board member from Daiichi-Sankyo. Dr. Raymond W. Lam has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from: Akili, Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, CME Institute, Hansoh, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, Medscape, Mind.Me, MITACS, Movember Foundation, Ontario Brain Institute, Otsuka, Pfizer, St. Jude Medical, University Health Network Foundation, and VGH-UBCH Foundation.

Publisher Copyright:
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

ASJC Scopus Subject Areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Empreinte numérique

Plonger dans les sujets de recherche 'Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force'. Ensemble, ils forment une empreinte numérique unique.

Citer